To guard against hype, scientists studying oxytocin’s role in autism and its potential as a treatment need to embrace robust theories, rigorous delivery methods and reproducible research practices.
Efforts to ease the symptoms of autism are beginning to ramp up, with promising candidates in various stages of testing.
Aripiprazole, an antipsychotic medication marketed as Abilify, eases aggressive behavior in autistic children, but questions remain about its side effects.
A new approach for delivering gene therapy to the brain reduces nerve damage in primates and could help make gene therapies for conditions related to autism safer.
Treatments for Rett syndrome that aim to boost levels of the protein MECP2 may not help everyone with the condition.
Intranasal oxytocin may spur new neuron growth and changes in social behavior after a few weeks.